Dezhan HealthCare Co Ltd (000813) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Dezhan HealthCare Co Ltd (000813) has a cash flow conversion efficiency ratio of 0.000x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-1.39 Million ≈ $-203.66K USD) by net assets (CN¥4.96 Billion ≈ $726.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Dezhan HealthCare Co Ltd for the company's overall valuation and market capitalisation.
Dezhan HealthCare Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Dezhan HealthCare Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Dezhan HealthCare Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Dezhan HealthCare Co Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Dezhan HealthCare Co Ltd to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DATATEC LTD (UNSP.ADR)/2
F:DTT0
|
N/A |
|
Tianjin Capital Environmental Protection Group Co Ltd
SHG:600874
|
0.238x |
|
Nobia AB
ST:NOBI
|
-0.026x |
|
Lihuayi Weiyuan Chemical Co Ltd
SHG:600955
|
0.007x |
|
Monex S.A.B. de C.V
MX:MONEXB
|
-1.308x |
|
Zhejiang Southeast Space Frame Co Ltd
SHE:002135
|
-0.139x |
|
Vivenio Residencial SOCIMI S.A.
MC:YVIV
|
0.018x |
|
Wonders Information
SHE:300168
|
-0.037x |
Annual Cash Flow Conversion Efficiency for Dezhan HealthCare Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Dezhan HealthCare Co Ltd from 1998 to 2025. View 000813 live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥4.57 Billion ≈ $669.10 Million |
CN¥4.72 Million ≈ $691.05K |
0.001x | +136.56% |
| 2024-12-31 | CN¥5.16 Billion ≈ $755.79 Million |
CN¥-14.59 Million ≈ $-2.13 Million |
-0.003x | -111.58% |
| 2023-12-31 | CN¥5.24 Billion ≈ $766.99 Million |
CN¥127.87 Million ≈ $18.71 Million |
0.024x | -20.29% |
| 2022-12-31 | CN¥5.28 Billion ≈ $773.22 Million |
CN¥161.72 Million ≈ $23.66 Million |
0.031x | +294.75% |
| 2021-12-31 | CN¥5.47 Billion ≈ $800.43 Million |
CN¥42.41 Million ≈ $6.21 Million |
0.008x | -94.42% |
| 2020-12-31 | CN¥5.95 Billion ≈ $871.12 Million |
CN¥827.54 Million ≈ $121.09 Million |
0.139x | -49.96% |
| 2019-12-31 | CN¥5.61 Billion ≈ $821.16 Million |
CN¥1.56 Billion ≈ $228.10 Million |
0.278x | +286.30% |
| 2018-12-31 | CN¥5.28 Billion ≈ $772.85 Million |
CN¥379.78 Million ≈ $55.57 Million |
0.072x | -15.02% |
| 2017-12-31 | CN¥4.55 Billion ≈ $665.14 Million |
CN¥384.64 Million ≈ $56.28 Million |
0.085x | +21.00% |
| 2016-12-31 | CN¥3.75 Billion ≈ $548.97 Million |
CN¥262.36 Million ≈ $38.39 Million |
0.070x | -23.14% |
| 2015-12-31 | CN¥1.37 Billion ≈ $200.89 Million |
CN¥124.91 Million ≈ $18.28 Million |
0.091x | -9.86% |
| 2014-12-31 | CN¥1.35 Billion ≈ $197.84 Million |
CN¥136.47 Million ≈ $19.97 Million |
0.101x | -16.57% |
| 2013-12-31 | CN¥1.41 Billion ≈ $206.33 Million |
CN¥170.59 Million ≈ $24.96 Million |
0.121x | +204.23% |
| 2012-12-31 | CN¥415.20 Million ≈ $60.76 Million |
CN¥16.51 Million ≈ $2.42 Million |
0.040x | +197.44% |
| 2011-12-31 | CN¥428.93 Million ≈ $62.77 Million |
CN¥-17.50 Million ≈ $-2.56 Million |
-0.041x | +56.93% |
| 2010-12-31 | CN¥425.26 Million ≈ $62.23 Million |
CN¥-40.29 Million ≈ $-5.90 Million |
-0.095x | -211.41% |
| 2009-12-31 | CN¥423.61 Million ≈ $61.99 Million |
CN¥36.03 Million ≈ $5.27 Million |
0.085x | -27.99% |
| 2008-12-31 | CN¥478.64 Million ≈ $70.04 Million |
CN¥56.53 Million ≈ $8.27 Million |
0.118x | +906.90% |
| 2007-12-31 | CN¥470.05 Million ≈ $68.78 Million |
CN¥-6.88 Million ≈ $-1.01 Million |
-0.015x | -129.17% |
| 2006-12-31 | CN¥450.91 Million ≈ $65.98 Million |
CN¥22.62 Million ≈ $3.31 Million |
0.050x | -87.82% |
| 2005-12-31 | CN¥327.22 Million ≈ $47.88 Million |
CN¥134.83 Million ≈ $19.73 Million |
0.412x | +172.81% |
| 2004-12-31 | CN¥296.13 Million ≈ $43.33 Million |
CN¥44.73 Million ≈ $6.55 Million |
0.151x | +1313.82% |
| 2003-12-31 | CN¥472.51 Million ≈ $69.14 Million |
CN¥-5.88 Million ≈ $-860.37K |
-0.012x | -126.33% |
| 2002-12-31 | CN¥676.78 Million ≈ $99.03 Million |
CN¥31.98 Million ≈ $4.68 Million |
0.047x | +145.23% |
| 2001-12-31 | CN¥650.49 Million ≈ $95.19 Million |
CN¥-67.96 Million ≈ $-9.95 Million |
-0.104x | -65.03% |
| 2000-12-31 | CN¥650.09 Million ≈ $95.13 Million |
CN¥-41.16 Million ≈ $-6.02 Million |
-0.063x | -176.18% |
| 1999-12-31 | CN¥639.51 Million ≈ $93.58 Million |
CN¥53.15 Million ≈ $7.78 Million |
0.083x | -49.57% |
| 1998-12-31 | CN¥612.87 Million ≈ $89.68 Million |
CN¥101.00 Million ≈ $14.78 Million |
0.165x | -- |
About Dezhan HealthCare Co Ltd
Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company offers atorvastatin calcium tablets, amlodipine-atorvastatin calcium tablets, warfarin sodium tablets, trimetazidine hydrochloride tablets, amiodarone hydrochloride tablets, as well as other drugs, including fam… Read more